Bilateral trigeminal enhancement on magnetic resonance imaging in a patient with multiple sclerosis and trigeminal neuralgia

Multiple Sclerosis

Volumn 13, Issue 6, 2007, Pages 814-816

  Pichiecchio, Anna ^a   Bergamaschi, R ^a   Tavazzi, E ^a   Romani, A ^a   Todeschini, A ^b   Bastianello, S ^a  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Magnetic resonance imaging; Multiple sclerosis; Trigeminal enhancement; Trigeminal neuralgia

Indexed keywords

GADOLINIUM; METHYLPREDNISOLONE; MYELIN; STEROID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; HUMAN; HYPERTROPHY; IMAGE ANALYSIS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; TRIGEMINAL NERVE; TRIGEMINUS NEURALGIA;

ADULT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; TRIGEMINAL NERVE; TRIGEMINAL NEURALGIA;

EID: 34447498944     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506075261     Document Type: Article

References (7)

1. Gass A, Kitchen N, MacManus DG, Moseley IF, Hennerici MG, Miller DH et al. Trigeminal neuralgia in patients with multiple sclerosis: lesion location with magnetic resonance imaging. Neurology 1997; 49: 114-44.
2. Meaney JF, Watt JW, Eldridge JWG, Whitehouse GH, Wells JCD, Miles JB. Association between trigeminal neuralgia and multiple sclerosis: role of magnetic resonance imaging. J Neurol Neurosurg Psychiatry 1995; 59(3): 253-59.
3. van der Meijs, Tan IL, Barkhof F. Incidence of enhancement of the trigeminal nerve on MRI in patients with multiple sclerosis. Mult Scler 2002; 8: 64-67.
4. da Silva CJ, da Rocha AJ, Mendes MF, Maia ACM Jr, Braga FT, Tilbey CP. Trigeminal involvement in multiple sclerosis: magnetic resonance imaging findings with clinical correlation in a series of patients. Mult Scler 2005; 11: 282-8S.
5. Bergamaschi R, Romani A, Zappoli F, Versino M, Cosi V. MRI and brainstern auditory evoked potential evidence in eight cranial nerve involvement in multiple sclerosis. Neurology 1997;48: 270-72.
6. Brinkemeier H, Aulkmeyer P, Wollinsky KH, Rudel R. An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system. Nat Med 2000; 6(7): 808-11.
7. Couratier P, Boukris S, Magy L, Traorè H, Vallat JM. Sclérose en plaques et atteinte du système nerveux péripherique. Rev Neurol (Paris) 2004; 160: 12, 1159-63.